Pith. sign in

REVIEW 2 major objections 2 minor 47 references

AI-Driven SERS for Non-invasive and Label-Free Extracellular Vesicle Detection Across Cellular Origins in Tears and Sweat

T0 review · 2 major / 2 minor · reviewed 2026-06-29 · grok-4.3

Challenge this review Re-run · record.json Download PDF Read on arXiv ↗ Review JSON

Pith's one-line read AI-assisted SERS with salt aggregation distinguishes extracellular vesicle cell origins in tears and sweat at over 92 percent accuracy without labels or separation.

desk verdict This extends SERS-AI EV classification to tears and sweat from six cell lines with claimed >92% accuracy on disease samples, but the abstract gives no evidence that the signals survive matrix interference or that the model avoids overfitting. read the letter →

arxiv 2605.25465 v1 pith:7YQD5YEX submitted 2026-05-25 cond-mat.mes-hall physics.data-anphysics.opticsq-bio.QM

Yang Li , Xiaoming Lyu , Ling Xia , Kuo Zhan , Haoyu Ji , Lei Qin , Seppo J. Vainio , Jian-An Huang This is my paper · ORCID
classification cond-mat.mes-hallphysics.data-anphysics.opticsq-bio.QM
keywords SERSextracellularvesicleslabel-freedetectiontearssweatAIclassificationnanoparticleaggregation
verification ladder T0 review T1 audit T2 compute T3 formal

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The reading

The paper develops a method that combines surface-enhanced Raman spectroscopy with artificial intelligence to detect and classify extracellular vesicles directly in tears and sweat. It shows that spectra from EVs secreted by six different cell lines can be differentiated by an AI model after salt-induced nanoparticle aggregation. This classification extends to identifying EV sources in tear samples from seven disease conditions at accuracies above 92 percent. The approach avoids chemical labels and physical separation steps that slow conventional EV analysis. A sympathetic reader would care because the work targets continuous, non-invasive monitoring in wearable formats for potential disease diagnosis.

What carries the argument

Salt-induced nanoparticle aggregation that generates reproducible SERS spectra from EVs, which are then classified by a deep-learning model trained on spectra from known cell-line EVs.

What would settle it

A test in which tears or sweat spiked with known mixtures of EVs from two different cell lines plus common biofluid proteins are run through the SERS-AI pipeline and yield classification accuracy below 80 percent.

Watch

Extended reading notes

Core claim

The central claim is that salt-induced aggregation of silver nanoparticles produces SERS spectra from EVs that carry sufficient origin-specific information for an AI model to identify the secreting cell line, and that this holds for EVs recovered from tear fluids across multiple disease states at greater than 92 percent accuracy while remaining label-free and separation-free.

Load-bearing premise

The spectral patterns produced after salt aggregation remain distinctive for each EV cell origin even when other molecules from tears or sweat are present in the sample.

Editorial extensions

If this is right

  • EVs from HepG2, Hela, 143B, LO-2, BMSC, and H8 cell lines produce distinguishable SERS signatures after aggregation.
  • The same pipeline identifies EV sources in tears from seven different disease conditions above 92 percent accuracy.
  • Molecular dynamics indicate silver atoms bind electrostatically to oxygen atoms on amino-acid residues, supporting protein-mediated attachment to the nanoparticles.
  • No chemical labeling or physical separation steps are required to obtain selective, reproducible signals from the biofluids.

Reading between the lines

Editorial extensions of the paper, not claims the author makes directly.

  • The platform could be miniaturized into wearable patches that sample sweat continuously for real-time EV monitoring.
  • If the spectral features prove stable across patients, the method might reduce reliance on blood draws for EV-based diagnostics.
  • Extension to other biofluids such as saliva would test whether the aggregation chemistry remains selective outside tears and sweat.
Share X Bluesky LinkedIn Reddit HN

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, simulated authors' rebuttal, and a circularity audit.

Referee Report

2 major / 2 minor

Summary. The manuscript presents an AI-assisted SERS platform employing salt-induced silver nanoparticle aggregation for label-free detection and differentiation of extracellular vesicles (EVs) secreted by six cell lines (HepG2, Hela, 143B, LO-2, BMSC, H8). It claims this enables identification of EVs in native tear fluids from seven disease sources with accuracies exceeding 92%, while also demonstrating applicability to sweat; molecular dynamics simulations are used to attribute signal generation to electrostatic Ag–O contacts with amino-acid residues.

Significance. If the specificity and robustness claims hold after proper validation, the work would represent a meaningful step toward non-invasive, point-of-care EV profiling in accessible biofluids, extending prior SERS+AI approaches from blood to tears and sweat. The inclusion of MD simulations to rationalize nanoparticle–protein affinity is a positive methodological feature.

major comments (2)
  1. [Abstract and Results (EV identification in tear fluids)] The central accuracy claim (>92% on seven disease tear sources) is load-bearing yet rests on an untested transfer assumption: that cell-line-specific EV spectral features remain dominant after salt-induced aggregation inside native tear/sweat matrices. The MD simulation (Ag–O electrostatic contacts) actually highlights a mechanism that is generic to many proteins and metabolites present in tears, creating a concrete risk of confounding that is not addressed by any reported control or ablation experiment.
  2. [Methods (AI model description)] No details are supplied on the deep-learning architecture, training/validation splits, cross-validation scheme, sample sizes per class, or statistical error bars. Without these, the reported accuracies cannot be evaluated for post-hoc model selection or overfitting, directly undermining the empirical claim.
minor comments (2)
  1. [Abstract] The abstract states that the platform works 'without a need for chemical labeling or separation steps,' yet the salt-induced aggregation protocol itself constitutes a sample-preparation step whose reproducibility across biofluids should be quantified.
  2. [Figures] Figure captions and axis labels should explicitly state the number of independent biological replicates and the cross-validation strategy used for each accuracy number.

Simulated Author's Rebuttal

2 responses · 0 unresolved

We thank the referee for the detailed and constructive report. The comments identify key areas where additional clarification and validation will strengthen the manuscript. We address each major comment below and will incorporate the necessary revisions.

read point-by-point responses

  1. Referee: [Abstract and Results (EV identification in tear fluids)] The central accuracy claim (>92% on seven disease tear sources) is load-bearing yet rests on an untested transfer assumption: that cell-line-specific EV spectral features remain dominant after salt-induced aggregation inside native tear/sweat matrices. The MD simulation (Ag–O electrostatic contacts) actually highlights a mechanism that is generic to many proteins and metabolites present in tears, creating a concrete risk of confounding that is not addressed by any reported control or ablation experiment.

    Authors: We agree that demonstrating robustness against potential confounders in native biofluids is essential. The MD simulations were intended to explain the nanoparticle–EV protein interaction mechanism rather than claim exclusivity, but we acknowledge that generic Ag–O contacts could involve other tear components. In the revised manuscript we will add control experiments including (i) SERS spectra of tear fluid depleted of EVs, (ii) mixtures of common tear proteins and metabolites without EVs, and (iii) ablation studies removing specific EV subpopulations. These will be used to quantify the contribution of EV-specific signals versus background and to support the reported accuracies. revision: yes

  2. Referee: [Methods (AI model description)] No details are supplied on the deep-learning architecture, training/validation splits, cross-validation scheme, sample sizes per class, or statistical error bars. Without these, the reported accuracies cannot be evaluated for post-hoc model selection or overfitting, directly undermining the empirical claim.

    Authors: We apologize for the incomplete methods description. The revised manuscript will include: the exact neural-network architecture (including layer types, hyperparameters, and loss function), the train/validation/test split ratios and randomization procedure, the cross-validation scheme (e.g., 5-fold stratified), the number of independent spectra per class (cell-line EVs and disease tear samples), and statistical error bars (standard deviation across folds or bootstrap resampling) together with the appropriate significance tests. These additions will allow readers to assess overfitting risk and reproducibility. revision: yes

Circularity Check

0 steps flagged · score 0.0 of 10

No circularity: purely empirical reporting of measured classification accuracies

full rationale

The manuscript contains no equations, derivations, or predictive models whose outputs are constructed from fitted inputs. All reported results (>92% accuracy on tear-fluid EV classification) are direct experimental measurements of AI performance on acquired SERS spectra. The MD simulation is used only to interpret nanoparticle-protein affinity and does not enter the classification pipeline or reduce any claim to a self-referential fit. Self-citations, if present, are not load-bearing for the central empirical result. This is a standard non-circular empirical study.

Assumptions & free parameters 0 free parameters · 0 assumptions · 0 invented entities

The paper is purely experimental with no mathematical derivations, free parameters in equations, or postulated entities; the central claim rests on empirical SERS measurements and AI classification performance.

how reviews work

0 comments
Cite this review

Pith. "Pith review of AI-Driven SERS for Non-invasive and Label-Free Extracellular Vesicle Detection Across Cellular Origins in Tears and Sweat." pith.science (2026). https://pith.science/paper/7YQD5YEX

@misc{pith2026260525465,
  author       = {Pith},
  title        = {Pith review of: AI-Driven SERS for Non-invasive and Label-Free Extracellular Vesicle Detection Across Cellular Origins in Tears and Sweat},
  year         = {2026},
  howpublished = {\url{https://pith.science/paper/7YQD5YEX}},
  note         = {Machine review of arXiv:2605.25465}
}
read the original abstract

Wearable sensing technology capable of point-of-care, continuous and non-invasive analysis of exosomes in biofluid such as tears and sweat is an essential part for future personalized medicine. Major detection and identification methods of cell secreted Extracellular Vesicles (EVs) often require labeling and are time-consuming, resulting in low efficiency in EV mechanism research and disease diagnosis. While the label-free Surface-enhanced Raman spectroscopy (SERS) has been combined with deep learning model for EV identification in blood, their application to non-invasive detection of EVs in tears and sweat are missing. Here, we filled this gap by developing an artificial intelligence (AI)-assisted Surface-enhanced Raman spectroscopy (SERS) method based on salt-induced nanoparticle aggregation for fast EV identification in tears and sweat with high accuracy. Significantly, our label-free detection and AI differentiation of EVs from 6 cell lines (HepG2, Hela, 143B, LO-2, BMSC, H8) achieved the identification of EVs in tear fluids from 7 different disease sources with accuracies >92%. Our results showed that this platform can not only distinguish EVs from multiple cell sources but also generate highly reproducible and selective EV signals in tear fluids without a need for chemical labeling or separation steps. Molecular dynamics simulations revealed that silver atoms (Ag) form electrostatic interactions with oxygen atoms of multiple amino acid residues in proteins, suggesting a high affinity. This strategy realizes ultra-sensitive and anti-interference detection of EVs, providing a new idea for the rapid diagnosis of clinical diseases.

Figures

Figures reproduced from arXiv: 2605.25465 by the authors.

Figure 3
Figure 3. Molecular dynamics simulation of the [PITH_FULL_IMAGE:figures/full_fig_p015_3.png] view at source ↗

Discussion (0). Continue with ORCID to comment.

Reference graph

Works this paper leans on

47 extracted references

  1. [1]

    Introduction Cell Secreted Extracelular nano - or microsize molecularly loaded vesicles (Exosomes when derived from the multivesical bodies) are lipid and corona encircled vesicles that are actively assembled and secreted by most of not all living cells, with a diameter that typically is around 30-150 nm. EVs transmit nucleic acids, proteins, and lipids, ...

  2. [2]

    Silver nitrate (AgNO3, ACS, 99.9%) was purchased from Alfa Aesar (China) Chemical Co

    Materials and methods 2.1 Chemicals and reagents DMEM high glucose medium was purchased from Gibco, F12 medium was purchased from Sigma-Aldrich, and all cell lines were purchased from American Type Culture Collection (ATCC, China). Silver nitrate (AgNO3, ACS, 99.9%) was purchased from Alfa Aesar (China) Chemical Co. Ltd; sodium borohydride (99.99%) was pu...

  3. [3]

    cleanser

    Results and discussion 3.1 Isolation and characterization of EVs Ultracentrifugation is the gold standard for the isolation of EVs [42], including differential centrifugation and density gradient centrifugation, in which differential centrifugation does not require the addition of additional reagents and does not interfere with the process of label -free ...

  4. [4]

    We combined it with the PCA-SVM model to classify and predict EVs from different cellular sources, and the accuracy of identifying EVs from six cellular sources reached 94.4%

    Conclusions In conclusion, we developed a label -free method for rapid detection of EVs from different cellular sources and biological fluid-derived samples. We combined it with the PCA-SVM model to classify and predict EVs from different cellular sources, and the accuracy of identifying EVs from six cellular sources reached 94.4%. Building on this founda...

  5. [5]

    Špilak, A

    A. Špilak, A. Brachner, U. Kegler, W. Neuhaus, C. Noehammer, Implications and pitfalls for cancer diagnostics exploiting extracellular vesicles, Advanced Drug Delivery Reviews, 175(2021) 113819

    2021

  6. [6]

    Staubach, F.N

    S. Staubach, F.N. Bauer, T. Tertel, V . Börger, O. Stambouli, D. Salzig, et al., Scaled preparation of extracellular vesicles from conditioned media, Advanced Drug Delivery Reviews, 177(2021) 113940

    2021

  7. [7]

    Hessvik, A

    N.P. Hessvik, A. Llorente, Current knowledge on exosome biogenesis and release, Cellular and Molecular Life Sciences, 75(2018) 193-208

    2018

  8. [8]

    Jara -Acevedo, C

    R. Jara -Acevedo, C. Campos -Silva, M. V alés -Gómez, M. Yáñez -Mó, H. Suárez, M. Fuentes, Exosome beads array for multiplexed phenotyping in cancer, Journal of Proteomics, 198(2019) 87-97

    2019

Show all 47 references
  1. [9]

    F. Teng, M. Fussenegger, Shedding Light on Extracellular V esicle Biogenesis and Bioengineering, Advanced Science, 8(2021) 2003505

    2021

  2. [10]

    Regev -Rudzki, D.W

    N. Regev -Rudzki, D.W. Wilson, T.G. Carvalho, X. Sisquella, B.M. Coleman, M. Rug, et al., Cell - Cell Communication between Malaria -Infected Red Blood Cells via Exosome -like V esicles, CELL, 153(2013) 1120-33

    2013

  3. [11]

    V yas, J

    N. V yas, J. Dhawan, Exosomes: mobile platforms for targeted and synergistic signaling across cell boundaries, CELLULAR AND MOLECULAR LIFE SCIENCES, 74(2017) 1567-76

    2017

  4. [12]

    Meldolesi, Exosomes and Ectosomes in Intercellular Communication, CURRENT BIOLOGY , 28(2018) R435-R44

    J. Meldolesi, Exosomes and Ectosomes in Intercellular Communication, CURRENT BIOLOGY , 28(2018) R435-R44

    2018

  5. [13]

    C. Zong, C. -j. Chen, X. Wang, P. Hu, G. -k. Liu, B.J.A.C. Ren, Single -molecule level rare events revealed by dynamic surface-enhanced Raman spectroscopy, 92(2020) 15806-10

    2020

  6. [14]

    S. Pan, Y . Zhang, M. Huang, Z. Deng, A. Zhang, L. Pei, et al., Urinary exosomes-based Engineered Nanovectors for Homologously Targeted Chemo -Chemodynamic Prostate Cancer Therapy via abrogating EGFR/AKT/NF-kB/IkB signaling, Biomaterials, 275(2021) 120946

    2021

  7. [15]

    Li, Y .R

    J. Li, Y .R. Li, S. Chen, W.L. Duan, X. Kong, Y .S. Wang, et al., Highly Sensitive Exosome Detection for Early Diagnosis of Pancreatic Cancer Using Immunoassay Based on Hierarchical Surface-Enhanced Raman Scattering Substrate, Small Methods, 6(2022)

    2022

  8. [16]

    Zhou, K.L

    B.T. Zhou, K.L. Xu, X. Zheng, T. Chen, J. Wang, Y .M. Song, et al., Application of exosomes as liquid biopsy in clinical diagnosis, Signal Transduction and Targeted Therapy, 5(2020)

    2020

  9. [17]

    Li, Y .R

    J. Li, Y .R. Li, P.L. Li, Y . Zhang, L.T. Du, Y .S. Wang, et al., Exosome detection via surface-enhanced Raman spectroscopy for cancer diagnosis, Acta Biomaterialia, 144(2022) 1-14

    2022

  10. [18]

    H.L. Shao, H. Im, C.M. Castro, X. Breakefield, R. Weissleder, H.H. Lee, New Technologies for Analysis of Extracellular V esicles, Chemical Reviews, 118(2018) 1917-50

    2018

  11. [19]

    K. Ueda, N. Ishikawa, A. Tatsuguchi, N. Saichi, R. Fujii, H. Nakagawa, Antibody -coupled monolithic silica microtips for highthroughput molecular profiling of circulating exosomes, Scientific Reports, 4(2014)

    2014

  12. [20]

    C. Liu, X. Xu, B. Li, B. Situ, W. Pan, Y . Hu, et al., Single -Exosome-Counting Immunoassays for Cancer Diagnostics, Nano letters, 18(2018) 4226-32

    2018

  13. [21]

    Y . Cao, Y . Wang, X. Y u, X. Jiang, G. Li, J. Zhao, Identification of programmed death ligand -1 positive exosomes in breast cancer based on DNA amplification -responsive metal-organic frameworks, Biosensors and Bioelectronics, 166(2020) 112452

    2020

  14. [22]

    X. Zhao, W. Zhang, X. Qiu, Q. Mei, Y . Luo, W. Fu, Rapid and sensitive exosome detection with CRISPR/Cas12a, Analytical and Bioanalytical Chemistry, 412(2020) 601-9

    2020

  15. [23]

    Jiang, X

    Q.-Y . Jiang, X. Cui, Y . Sun, Z. Mao, J. Wang, F. Chen, et al., Crown monitoring: Trace the dynamic changes of caspase -3 and H2O2 in real -time imaging based on FRET/SERS, Biosensors and Bioelectronics, 192(2021) 113539

    2021

  16. [24]

    D. Wang, G. Xu, X. Zhang, H. Gong, L. Jiang, G. Sun, et al., Dual-functional ultrathin wearable 3D particle-in-cavity SF -AAO-Au SERS sensors for effective sweat glucose and lab -on-glove pesticide detection, Sensors and Actuators B: Chemical, 359(2022) 131512

    2022

  17. [25]

    J. -A. Huang, M.Z. Mousavi, Y . Zhao, A. Hubarevich, F. Omeis, G. Giovannini, et al., SERS discrimination of single DNA bases in single oligonucleotides by electro -plasmonic trapping, Nature Communications, 10(2019) 5321

    2019

  18. [26]

    B. Zhao, T. Yang, Y . Qu, A.J. Mills, G. Zhang, L. He, Rapid capture and SERS detection of triclosan using a silver nanoparticle core – protein satellite substrate, Science of The Total Environment, 716(2020) 137097

    2020

  19. [27]

    Zhang, M

    J. Zhang, M. Peng, E. Lian, L. Xia, A.G. Asimakopoulos, S. Luo, et al., Identification of Poly(ethylene terephthalate) Nanoplastics in Commercially Bottled Drinking Water Using Surface - Enhanced Raman Spectroscopy, Environmental Science & Technology, (2023)

    2023

  20. [28]

    H. Shin, D. Seo, Y . Choi, Extracellular V esicle Identification Using Label-free Surface-Enhanced Raman Spectroscopy: Detection and Signal Analysis Strategies, Molecules, 25(2020) 5209

    2020

  21. [29]

    S. Zong, L. Wang, C. Chen, J. Lu, D. Zhu, Y . Zhang, et al., Facile detection of tumor -derived exosomes using magnetic nanobeads and SERS nanoprobes, Analytical Methods, 8(2016) 5001-8

    2016

  22. [30]

    Y . Pang, J. Shi, X. Y ang, C. Wang, Z. Sun, R. Xiao, Personalized detection of circling exosomal PD- L1 based on Fe3O4@TiO2 isolation and SERS immunoassay, Biosensors and Bioelectronics, 148(2020) 111800

    2020

  23. [31]

    Z. Han, X. Peng, Y . Yang, J. Yi, D. Zhao, Q. Bao, et al., Integrated microfluidic-SERS for exosome biomarker profiling and osteosarcoma diagnosis, Biosensors and Bioelectronics, 217(2022) 114709

    2022

  24. [32]

    Lee, R.P

    C. Lee, R.P. Carney, S. Hazari, Z.J. Smith, A. Knudson, C.S. Robertson, et al., 3D plasmonic nanobowl platform for the study of exosomes in solution, Nanoscale, 7(2015) 9290-7

    2015

  25. [33]

    Stremersch, M

    S. Stremersch, M. Marro, B.E. Pinchasik, P. Baatsen, A. Hendrix, S.C. De Smedt, et al., Identification of Individual Exosome -Like V esicles by Surface Enhanced Raman Spectroscopy, Small, 12(2016) 3292-301

    2016

  26. [34]

    S. Dong, Y . Wang, Z. Liu, W. Zhang, K. Yi, X. Zhang, et al., Beehive-Inspired Macroporous SERS Probe for Cancer Detection through Capturing and Analyzing Exosomes in Plasma, ACS Applied Materials & Interfaces, 12(2020) 5136-46

    2020

  27. [35]

    Lussier, V

    F. Lussier, V . Thibault, B. Charron, G.Q. Wallace, J. -F. Masson, Deep learning and artificial intelligence methods for Raman and surface -enhanced Raman scattering, TrAC Trends in Analytical Chemistry, 124(2020) 115796

    2020

  28. [36]

    C. Lin, S. Liang, Y . Peng, L. Long, Y . Li, Z. Huang, et al., Visualized SERS Imaging of Single Molecule by Ag/Black Phosphorus Nanosheets, Nano-Micro Letters, 14(2022) 75

    2022

  29. [37]

    Y . Ju, O. Neumann, M. Bajomo, Y . Zhao, P. Nordlander, N.J. Halas, et al., Identifying Surface - Enhanced Raman Spectra with a Raman Library Using Machine Learning, ACS Nano, 17(2023) 21251- 61

    2023

  30. [38]

    X. Bi, L. Lin, Z. Chen, J. Ye, Artificial Intelligence for Surface -Enhanced Raman Spectroscopy, Small Methods, n/a(2023) 2301243

    2023

  31. [39]

    Zhang, S

    Z. Zhang, S. Jiang, H. Jiang, X. Lyu, Y . Wang, T. Dong, et al., Rapid genotype recognition of human adenovirus based on surface-enhanced Raman scattering combined with machine learning, Sensors and Actuators B: Chemical, 400(2024) 134873

    2024

  32. [40]

    Živanović, S

    V . Živanović, S. Seifert, D. Drescher, P. Schrade, S. Werner, P. Guttmann, et al., Optical Nanosensing of Lipid Accumulation due to Enzyme Inhibition in Live Cells, ACS Nano, 13(2019) 9363-75

    2019

  33. [41]

    Shin, B.H

    H. Shin, B.H. Choi, O. Shim, J. Kim, Y . Park, S.K. Cho, et al., Single test-based diagnosis of multiple cancer types using Exosome-SERS-AI for early stage cancers, Nature Communications, 14(2023) 1644

    2023

  34. [42]

    urchin-like

    K. Li, X. Tang, G. Liu, J. Mi, J. Du, W. Huang, et al., An efficient double template strategy to construct large-area and highly ordered silver “urchin-like” arrays for sensitive SERS analysis, 570(2021) 151069

    2021

  35. [43]

    L. Wang, T. Guo, Q. Lu, X. Yan, D. Zhong, Z. Zhang, et al., Sea-Urchin-Like Au Nanocluster with Surface-Enhanced Raman Scattering in Detecting Epidermal Growth Factor Receptor (EGFR) Mutation Status of Malignant Pleural Effusion, ACS Applied Materials & Interfaces, 7(2015) 359-69

    2015

  36. [44]

    H. Dies, J. Raveendran, C. Escobedo, A. Docoslis, Rapid identification and quantification of illicit drugs on nanodendritic surface -enhanced Raman scattering substrates, Sensors and Actuators B: Chemical, 257(2018) 382-8

    2018

  37. [45]

    Huang, B

    X. Huang, B. Liu, S. Guo, W. Guo, K. Liao, G. Hu, et al., SERS spectroscopy with machine learning to analyze human plasma derived sEVs for coronary artery disease diagnosis and prognosis, Bioengineering & Translational Medicine, 8(2023) e10420

    2023

  38. [46]

    F. Royo, C. Théry, J.M. Falcón -Pérez, R. Nieuwland, K.W. Witwer, Methods for Separation and Characterization of Extracellular V esicles: Results of a Worldwide Survey Performed by the ISEV Rigor and Standardization Subcommittee, Cells, 9(2020)

    2020

  39. [47]

    Fu, X.-D

    B.-B. Fu, X.-D. Tian, J.-J. Song, B.-Y . Wen, Y .-J. Zhang, P.-P. Fang, et al., Self-calibration 3D hybrid SERS substrate and its application in quantitative analysis, 94(2022) 9578-85

    2022

Pith tools

Reviewed June 29, 2026 · model on record in the stance chip above.